Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Referral of Patients to Dermatology and Teledermatology Consultations in Spain. DIADERM Study.

González-López G, Descalzo-Gallego MÁ, Arias-Santiago S, Molina-Leyva A, Gilaberte Y, Fernández-Crehuet P, Husein-El Ahmed H, Viera-Ramírez A, Fernández-Peñas P, Taberner R, García-Doval I, Buendía-Eisman A; Coordinadores de las secciones; Participantes.

Actas Dermosifiliogr. 2019 Mar;110(2):146-152. doi: 10.1016/j.ad.2018.09.004. Epub 2018 Dec 21. English, Spanish.

PMID:
30583856
2.

Systemic antifungal therapy for tinea capitis in children: An abridged Cochrane Review.

Chen X, Jiang X, Yang M, Bennett C, González U, Lin X, Hua X, Xue S, Zhang M.

J Am Acad Dermatol. 2017 Feb;76(2):368-374. doi: 10.1016/j.jaad.2016.08.061. Epub 2016 Nov 2. Review.

PMID:
27816294
3.

Systemic antifungal therapy for tinea capitis in children.

Chen X, Jiang X, Yang M, González U, Lin X, Hua X, Xue S, Zhang M, Bennett C.

Cochrane Database Syst Rev. 2016 May 12;(5):CD004685. doi: 10.1002/14651858.CD004685.pub3. Review.

PMID:
27169520
4.

Vector and reservoir control for preventing leishmaniasis.

González U, Pinart M, Sinclair D, Firooz A, Enk C, Vélez ID, Esterhuizen TM, Tristan M, Alvar J.

Cochrane Database Syst Rev. 2015 Aug 5;(8):CD008736. doi: 10.1002/14651858.CD008736.pub2. Review.

5.

Interventions for vitiligo.

Whitton ME, Pinart M, Batchelor J, Leonardi-Bee J, González U, Jiyad Z, Eleftheriadou V, Ezzedine K.

Cochrane Database Syst Rev. 2015 Feb 24;(2):CD003263. doi: 10.1002/14651858.CD003263.pub5. Review.

PMID:
25710794
6.

Cochrane reviews on neglected diseases: the case of cutaneous leishmaniasis.

González U.

Cochrane Database Syst Rev. 2013 Mar 28;(3):ED000055. doi: 10.1002/14651858.ED000055. No abstract available.

PMID:
23641479
7.

Implications for Research: Getting the Most out of Cochrane Reviews.

González U, Williams H.

Cochrane Database Syst Rev. 2011 Dec 7;1:ED000037. doi: 10.1002/14651858.ED000037. No abstract available.

PMID:
22258938
8.

Guidelines for designing and reporting clinical trials in vitiligo.

González U, Whitton M, Eleftheriadou V, Pinart M, Batchelor J, Leonardi-Bee J.

Arch Dermatol. 2011 Dec;147(12):1428-36. doi: 10.1001/archdermatol.2011.235. Epub 2011 Aug 15. Review.

PMID:
21844427
9.

Comment on: Vitiligo Treatment in Childhood: a State of the Art Review. By Tamesis MEB, Morelli JG: Pediatric Dermatology 2010;27(5):437-455.

Batchelor JM, Whitton ME, Pinart M, Leonardi-Bee J, Gonzalez U.

Pediatr Dermatol. 2011 May-Jun;28(3):354-5; author reply 354. doi: 10.1111/j.1525-1470.2011.01442.x. No abstract available.

PMID:
21615480
10.

Designing and reporting clinical trials on treatments for cutaneous leishmaniasis.

González U, Pinart M, Reveiz L, Rengifo-Pardo M, Tweed J, Macaya A, Alvar J.

Clin Infect Dis. 2010 Aug 15;51(4):409-19. doi: 10.1086/655134. Review.

PMID:
20624067
11.

Interventions for vitiligo.

Whitton ME, Pinart M, Batchelor J, Lushey C, Leonardi-Bee J, González U.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD003263. doi: 10.1002/14651858.CD003263.pub4. Review. Update in: Cochrane Database Syst Rev. 2015;2:CD003263.

PMID:
20091542
12.

Interventions for American cutaneous and mucocutaneous leishmaniasis.

González U, Pinart M, Rengifo-Pardo M, Macaya A, Alvar J, Tweed JA.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD004834. doi: 10.1002/14651858.CD004834.pub2. Review.

PMID:
19370612
13.

Interventions for Old World cutaneous leishmaniasis.

González U, Pinart M, Reveiz L, Alvar J.

Cochrane Database Syst Rev. 2008 Oct 8;(4):CD005067. doi: 10.1002/14651858.CD005067.pub3. Review. Update in: Cochrane Database Syst Rev. 2017 Nov 17;11:CD005067.

PMID:
18843677
14.

Therapeutic interventions for vitiligo.

Whitton ME, Ashcroft DM, González U.

J Am Acad Dermatol. 2008 Oct;59(4):713-7. doi: 10.1016/j.jaad.2008.06.023. Review.

PMID:
18793940
15.

Cloud over sentinel node biopsy: unlikely survival benefit in melanoma.

González U.

Arch Dermatol. 2007 Jun;143(6):775-6. No abstract available.

PMID:
17576945
16.

Role of the CDKN2A locus in patients with multiple primary melanomas.

Puig S, Malvehy J, Badenas C, Ruiz A, Jimenez D, Cuellar F, Azon A, Gonzàlez U, Castel T, Campoy A, Herrero J, Martí R, Brunet-Vidal J, Milà M.

J Clin Oncol. 2005 May 1;23(13):3043-51.

PMID:
15860862
17.
18.

Fluconazole for cutaneous leishmaniasis: looking for a better treatment.

González U.

Arch Dermatol. 2002 Dec;138(12):1604-6. No abstract available.

PMID:
12472352

Supplemental Content

Loading ...
Support Center